Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.PuraMed BioScience, a US-based researcher, developer and marketer of over-the-counter (OTC) products, is nearing completion of its new non-prescription, hemp-based, homeopathic medication development to treat epilepsy symptoms including seizures and seizure-related headaches.
Subscribe to our email newsletter
Both epilepsy and migraines appear to be triggered by the same coritcal spreading depression (CSD) in the brain, and the difference between the two is the rate of reaction.
This may be why many people who suffer from migraines are prescribed epilepsy medications.
PuraMed BioScience CEO Russ Mitchell said by incorporating standardized hemp oil into its current patented, over-the-counter migraine relief formula, MigraPure, the company believes it can offer relief to people who not only suffer with migraines, but also offer relief to people who have seizure-related headaches and other epilepsy-type symptoms.
"Due to the close association between migraine headaches and epilepsy, the development of a hemp-based treatment for epilepsy symptoms is a logical step for the company to make," Mitchell said.
"Hemp-based cannabinoids combined with our experience in building herbal medicines that outperform traditional allopathic treatments fit extremely well with our unique delivery systems and our business philosophy."
In the US, epilepsy is the third most common neurological disorder affecting about 2.7 million people, with children and older adults being most susceptible.
Epilepsy also causes up to 50,000 sudden deaths each year.